Derisk Patient Evidence

Unlock Patient Insights Without Pharmacovigilance Burden

Pharmaceutical companies need to understand how patients experience their treatments, but traditional social listening carries the risk of detecting safety signals, triggering regulatory reporting obligations. With CuratedBase’s Derisk Patient Reporting, you can freely explore real-world patient feedback without the compliance concerns of pharmacovigilance.

Key features include intelligent querying, where users can input simple or complex questions, and the AI returns comprehensive trial summaries, eligibility criteria, locations, and outcomes. The copilot offers dynamic filtering options, allowing users to refine searches by disease, intervention, phase, location, or sponsor. With built-in visualization tools, users can explore trends, compare trials, and generate insights through intuitive dashboards. Additionally, the copilot ensures data relevance by continuously updating from real-time sources and identifying emerging patterns. Compliance and ethical considerations are integrated, making it a reliable resource for decision-making in drug development, academic research, and patient care.


Compliance

Extract key findings on treatment effectiveness and real-world usage — without triggering mandatory safety reporting obligations.

Anonymization | Removing personally identifiable information to protect privacy.

Synthetization | Structuring insights into generalizable narratives while eliminating individual case traceability.

Aggregation | Grouping data points to provide high-level trends without linking to specific patients.



Evidence

Fill the gaps in evidence needs

Patient Sentiment & Opinion | Understand how your product is perceived in real-world usage.

Effectiveness & Treatment Patterns | Gain insights into adherence, off-label use, and real-world outcomes.

Usage Trends | Identify how different patient groups interact with your product.

Safety Signals in a Controlled Manner | Detect potential issues early without generating direct pharmacovigilance cases.